Other Private Equity/Strategic Investments
Sun Pharma to acquire 16.33% in US-based Surgimatix for $3-M
Publicly listed Sun Pharmaceutical Industries is to acquire a 16.33% stake in Illinois (USA)-headquartered Surgimatix Inc, for USD 3.05 million (INR 25 crore).Surgimatix is engaged in developing a proprietary soft tissue fixation device for laparoscopic hernia repair and other minimally invasive surgeries. It is yet to commence its commercial operations.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
